Member Directory for The Center for RNA Genomic Medicine
Department: SR-CHEM-SHEN LAB Jessica Childs-Disney Research Assistant Professor Phone: (561) 228-2508 Email: jchildsdisney@ufl.edu ORCID: 0009-0001-7829-3240 Full Profile…
Posts tagged as
RNA
From Incurable to Treatable:
Looking to the Genome to Address ‘Undruggable’ Diseases including Parkinson’s, ALS, Cancer and More Biochemist Matthew Disney, Ph.D., has found that many incurable diseases can potentially be cured via key RNA. He’s racing against time to create novel treatments and get them to patients. Original…
A Special Place to Address Rare Diseases
The Journey from Molecule to Medicine – A Photo Tour From molecules to medicines, every cure begins with understanding. At the Wertheim UF Scripps Institute, we unlock tomorrow’s therapies by understanding the complexity of life. “We can also apply this to areas of unmet need that maybe a pharmaceutical…
Every Cure Begins With Understanding
stopping DiSease by understanding its root cause…
Scientists Blaze New Path to Fighting Viral Diseases
Mapping vulnerabilities in the SARS-CoV-2 genome, made of RNA, reveals a path to fighting more than COVID-19.
Scientist’s Parkinson’s Work Selected for Innovative Drug Development Effort
A Parkinson's disease project from the lab of chemist Matthew D. Disney, Ph.D., has received a boost from a nonprofit focused on helping scientists translate their discoveries into treatments.
Fired Up About Neurons: New Investigator Uncovers Brain Cell Biology Molecule by Molecule
Molecular biologist Ezgi Hacisuleyman, Ph.D., investigates how neurons respond to signals, changing in milliseconds. She recently joined the institute from The Rockefeller University.
Inspired by Greek Mythology, This Potential Drug Shows Promise for Vanquishing Parkinson’s RNA in Early Studies
A new discovery from the lab of chemist Matthew Disney, Ph.D., takes its inspiration from Greek mythology. The compound is a chimera, and it battles a toxic cause of Parkinson's in two ways.
Climbing a New Path Allows Chemists to Ascend Cancer’s Steepest Research Challenge, a Gene Called MYC
The scientists’ approach directs cells’ recycling enzymes to cancer genes’ RNA and cuts up key segments to prevent them from doing harm. The tactic worked against the MYC cancer gene, and also two other challenging cancer genes.
